NASDAQ : MDLN

Medline Inc.

$39.7 USD

$0.95 (2.45%)

Volume
4.32M
Average Volume
9.67M
Market Capitalization
$33.57B
P/E Ratio
32.81
Dividend Yield
0.00%
Price Target
$55.00
Year High
$50.88
Year Low
$32.82
Day High
Day Low
Payout Ratio
$0.10
Current Ratio
$4.41
Company Overview

NASDAQ

James Boyle

Medical - Instruments & Supplies

Healthcare

MDLN

45000

US

USD

(847) 949-5500

58507V107

0002046386

Liquidity Metrics

1.12

4.41

2.51

0.88

0.10

Sales & Valuation

$28.43B

1.15

2.88

22.01

1.86

Profitability

$1.43

$1.16B

3.31%

4.12%

6.87%

2.47%

P/E Metrics

32.81

12.91

12.91

Analyst Price Target & Rating

$55.00

$60.00

$42.00

Neutral

3/5

14 Analysts

-27.82%

Financial Health Scores

2.17

6/9

$8.64B

$39.01B

$19.66B

$1.8B

Key Metrics (TTM)

$43.17B

1.48

15.81

4.41

6.87%

5.01%

3.04%

4.65%

$19.09

110 days

Company Executives
Name Title
Douglas Golwas Chief Commercial Officer
Michael Drazin Chief Financial Officer
Stephen L. Miller Chief Operating Officer
Marshall Lancaster Chief Information Officer
Ben Fox Vice President of Corporate Communications
Alex Liberman Chief Legal Officer
James Boyle CEO & Director
Jessi L. Corcoran Chief Accounting Officer
Karen King Global Head Investor Relations
Jenny Lee Chief Marketing Officer
Poll Results

No votes yet today — be the first to share your view!

About Medline Inc. (NASDAQ:MDLN) Stock

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable ... medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Kaplan Fox & Kilsheimer LLP Announces an Investigation into Medline Inc. (MDLN) for Possible Securities Law Violations

2026-07-27 18:45:00

New York, New York--(Newsfile Corp. - July 27, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

2026-07-24 11:00:00

New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Medline strengthens California distribution network with new 1 million-square-foot facility in Perris

2026-07-20 13:44:00

Cutting-edge distribution center to reinforce Medline's supply chain resilience in California NORTHFIELD, Ill., July 20, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) has announced plans to open a new distribution center in Perris, Calif.

Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm

2026-07-20 12:45:00

New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

Kaplan Fox Alerts Medline Inc. (MDLN) Investors to an Investigation of Potential Securities Law Violations

2026-07-17 17:45:00

New York, New York--(Newsfile Corp. - July 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Medline investor and have suffered losses, or if you have information that could assist in the Medline investigation, you may CLICK HERE to contact us.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN

2026-07-09 17:32:00

NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. ("Medline" or the "Company") (NASDAQ: MDLN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

MDLN ALERT: HBSS Probes Medline (MDLN) After Reports Reveal Undisclosed Manufacturing Violations and Failed Contamination Investigations

2026-07-07 20:54:00

SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman Sobol Shapiro (HBSS) has launched an investigation into Medline Inc. (NASDAQ: MDLN) focusing on whether the company may have misled investors regarding the adequacy of its manufacturing quality controls and compliance with FDA safety standards. SUBMIT YOUR MDLN INVESTMENT LOSSES TO HBSS NOW The firm is looking into whether Medline concealed systemic lapses in its contamination protocols—specifically failures to investigate microbial incidents and batch discrepancies—that prompted regulatory scrutiny and triggered a significant decline in the company's share price.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN

2026-07-07 17:57:00

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Frequently Asked Questions

What is the current Medline Inc. (MDLN) stock price?

Medline Inc.(NASDAQ:MDLN) stock price is $39.7 in the last trading session. During the trading session, MDLN stock reached the peak price of $50.876 while $32.815 was the lowest point it dropped to. The percentage change in MDLN stock occurred in the recent session was 2.45% while the dollar amount for the price change in MDLN stock was $0.95.

MDLN's industry and sector of operation?

The NASDAQ listed MDLN is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of MDLN?

Douglas Golwas | Chief Commercial Officer
Michael Drazin | Chief Financial Officer
Stephen L. Miller | Chief Operating Officer
Marshall Lancaster | Chief Information Officer
Ben Fox | Vice President of Corporate Communications

How many employees does MDLN have?

Number of MDLN employees currently stands at 45000. MDLN operates from 3 Lakes Drive, Northfield, IL 60093, US.

Link for MDLN official website?

Official Website of MDLN is: https://www.medline.com

How do I contact MDLN?

MDLN could be contacted at phone #(847) 949-5500 and can also be accessed through its website. MDLN operates from 3 Lakes Drive, Northfield, IL 60093, US.

How many shares of MDLN are traded daily?

The average number of MDLN shares traded daily for last 3 months was 9.67M.

What is the market cap of MDLN currently?

The market value of MDLN currently stands at $33.57B with its latest stock price at $39.7